SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Medical Marijuana, Inc. (MJNA) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 20/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MJNA
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.05
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.01 |
$9.22M |
$25.97M |
281.8% |
| 2016 |
$-0.01 |
$8M |
$-25.91M |
-323.7% |
| 2017 |
$-0.05 |
$26.52M |
$-148.1M |
-558.4% |
| 2018 |
$-0.09 |
$59.83M |
$-202.93M |
-339.2% |
| 2019 |
$0.03 |
$75.56M |
$84.4M |
111.7% |
| 2020 |
$-0.03 |
$46.94M |
$-95.78M |
-204.1% |
| 2021 |
$0.00 |
$34.12M |
$-4.77M |
-14% |
| 2022 |
$0.00 |
$25.1M |
$-15.35M |
-61.2% |
| 2023 |
$0.00 |
$16.81M |
$-5.08M |
-30.2% |
| 2024 |
$0.00 |
$14.91M |
$-641.6K |
-4.3% |
